Sr. Manager – Policy, Access and Coverage Trends – Market Analysis and Strategy 126 views

  • Works on consumer / patient-related healthcare policy and trends affecting individual, employer and emerging purchasers of health care including macro issues that affect patient access to health care, benefit coverage, and purchasing decisions.
  • Affordable Care Act, patient cost burden, public Marketplaces, private exchanges, quality, cost transparency, decision support tools, benefit design, narrow networks, etc.
  • Partners with many functions throughout the organization (Government Affairs, Managed Care Marketing, Medical Affairs, Market Analysis & Strategy, etc.) and leads cross-functional teams to:
  • Understand and assess impact of patient issues
  • Outline implications for Genentech’s business, including access to and reimbursement of our products
  • Develop recommendations for go-forward, including how we interact / navigate with patients/purchasers of health care; this role is critical to informing insights for strategy development, but is not responsible for Genentech patient strategy or execution
  • Facilitates structured problem solving to answer key questions and manages project resources to successful outcomes (on time, on budget, within scope)
  • Develops and leads primary research, secondary data analytics, and modeling studies
  • Quantifies financial impact of issues (where relevant) to Genentech’s business, including patient, volume and revenue forecasting
  • Synthesizes data into actionable insights, strategies, and tactics, and creates findings reports / presentations
  • Presents findings and recommendations to Senior Leadership, including CEO and his direct reports
  • May have direct report/s so the ability to direct team members and guide work and performance would be a plus

Who you are

You’re someone who wants to influence your own development. You’re looking for a company where you have the opportunity to pursue your interests across functions and geographies. Where a job title is not considered the final definition of who you are, but the starting point.

  • Position is based in South San Francisco with limited travel as needed
  • Deep content expertise in healthcare policies, trends and issues, particularly from the patient / purchaser (individual, employer) point of view.
  • Prior public or private payer, provider, and/or healthcare patient advocacy / policy experience is a plus
  • Able to lead and influence cross-functional teams, including teams with Senior Leadership involvement or oversight
  • Able to navigate ambiguous problems and breakdown complex issues into manageable chunks for structured problem solving
  • Strong qualitative and quantitative reasoning skills
  • Strong primary research, secondary data analytics and modeling / scenario planning skills
  • Strong project management and team facilitation skills
  • Strong communication and presentation skills; ability to present to Senior Leadership, including CEO and his direct reports
  • MPH, MBA or advanced degree with at least 8 to 12 years related experience, or Bachelors degree with 10 to 14 years related experience in the healthcare industry, preferably with prior experience at a health plan, biotech company and/ or healthcare or strategy consulting firm
Share this job

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide. In 2016, Roche invested CHF 9.9 billion in R&D and posted sales of CHF 50.6 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

Connect with us